Operating Income (Loss) in USD of Alzamend Neuro, Inc. from 2019 to Q2 2025

Taxonomy & unit
us-gaap: USD
Description
The net result for the period of deducting operating expenses from operating revenues.
Summary
Alzamend Neuro, Inc. quarterly/annual Operating Income (Loss) history and growth rate from 2019 to Q2 2025.
  • Alzamend Neuro, Inc. Operating Income (Loss) for the quarter ending July 31, 2025 was -$2.7M, a 181% decline year-over-year.
  • Alzamend Neuro, Inc. Operating Income (Loss) for the twelve months ending July 31, 2025 was -$6.23M, a 15.5% increase year-over-year.
  • Alzamend Neuro, Inc. annual Operating Income (Loss) for 2024 was -$4.5M, a 54.8% increase from 2023.
  • Alzamend Neuro, Inc. annual Operating Income (Loss) for 2023 was -$9.94M, a 33.2% increase from 2022.
  • Alzamend Neuro, Inc. annual Operating Income (Loss) for 2022 was -$14.9M, a 20.7% decline from 2021.
Operating Income (Loss), Trailing 12 Months (USD)
Operating Income (Loss), Quarterly (USD)
Operating Income (Loss), YoY Quarterly Growth (%)
Operating Income (Loss), Annual (USD)
Operating Income (Loss), YoY Annual Growth (%)

Alzamend Neuro, Inc. Quarterly Operating Income (Loss) (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q2 2025 -$6.23M -$2.7M -$1.74M -181% May 1, 2025 Jul 31, 2025 10-Q 2025-09-10
Q1 2025 -$4.5M -$1.14M -$289K -34% Feb 1, 2025 Apr 30, 2025 10-K 2025-07-22
Q4 2024 -$4.21M -$1.04M +$1.62M +61% Nov 1, 2024 Jan 31, 2025 10-Q 2025-03-10
Q3 2024 -$5.83M -$1.36M +$1.54M +53.2% Aug 1, 2024 Oct 31, 2024 10-Q 2024-12-11
Q2 2024 -$7.37M -$962K +$2.56M +72.7% May 1, 2024 Jul 31, 2024 10-Q 2025-09-10
Q1 2024 -$9.94M -$850K +$2.45M +74.3% Feb 1, 2024 Apr 30, 2024 10-K 2025-07-22
Q4 2023 -$12.4M -$2.66M +$2.76M +51% Nov 1, 2023 Jan 31, 2024 10-Q 2025-03-10
Q3 2023 -$15.2M -$2.9M +$205K +6.59% Aug 1, 2023 Oct 31, 2023 10-Q 2024-12-11
Q2 2023 -$15.4M -$3.53M -$490K -16.2% May 1, 2023 Jul 31, 2023 10-Q 2024-09-11
Q1 2023 -$14.9M -$3.31M +$568K +14.7% Feb 1, 2023 Apr 30, 2023 10-K 2024-07-30
Q4 2022 -$15.4M -$5.42M -$2.87M -112% Nov 1, 2022 Jan 31, 2023 10-Q 2024-03-25
Q3 2022 -$12.6M -$3.11M +$478K +13.3% Aug 1, 2022 Oct 31, 2022 10-Q 2023-12-15
Q2 2022 -$13M -$3.04M -$729K -31.6% May 1, 2022 Jul 31, 2022 10-Q 2023-09-13
Q1 2022 -$12.3M -$3.87M -$2.65M -217% Feb 1, 2022 Apr 30, 2022 10-K 2023-07-27
Q4 2021 -$9.67M -$2.56M -$1.44M -129% Nov 1, 2021 Jan 31, 2022 10-Q 2023-03-15
Q3 2021 -$8.23M -$3.58M -$2.29M -176% Aug 1, 2021 Oct 31, 2021 10-Q 2022-12-12
Q2 2021 -$5.94M -$2.31M -$988K -74.9% May 1, 2021 Jul 31, 2021 10-Q 2022-09-13
Q1 2021 -$4.95M -$1.22M Feb 1, 2021 Apr 30, 2021 10-K 2022-07-19
Q4 2020 -$1.12M Nov 1, 2020 Jan 31, 2021 10-Q 2022-03-15
Q3 2020 -$1.3M Aug 1, 2020 Oct 31, 2020 10-Q 2021-12-13
Q2 2020 -$1.32M May 1, 2020 Jul 31, 2020 10-Q 2021-09-13

Alzamend Neuro, Inc. Annual Operating Income (Loss) (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2024 -$4.5M +$5.44M +54.8% May 1, 2024 Apr 30, 2025 10-K 2025-07-22
2023 -$9.94M +$4.93M +33.2% May 1, 2023 Apr 30, 2024 10-K 2025-07-22
2022 -$14.9M -$2.55M -20.7% May 1, 2022 Apr 30, 2023 10-K 2024-07-30
2021 -$12.3M -$7.37M -149% May 1, 2021 Apr 30, 2022 10-K 2023-07-27
2020 -$4.95M -$528K -11.9% May 1, 2020 Apr 30, 2021 10-K 2022-07-19
2019 -$4.42M May 1, 2019 Apr 30, 2020 10-K 2021-07-29
* An asterisk sign (*) next to the value indicates that the value is likely invalid.